BGB Group
Independent
Address
38 Greene St.
New York, New York 10014
Web Address
Year Founded
2005
Full-time Employees 2022
Offices
North America
2
Locations
New York, NY
Executives & Senior Management
Greg Passaretti
Founding Partner
Brendon Phalen, MD
Founding Partner
Teresa Day
President
Senior Management
Greg Passaretti
Founding Partner
Agency 100 T-Shirt
Capabilities/Services Offered
Professional
Consumer
Direct Marketing
Med-ed
Payer
Med-Tech
Public Health
Data/Analytics
Digital
Medical affairs
New Services
SCHEMA: Creating a distinct value proposition for each brand begins with uncovering value drivers and access challenges. This serves to inform the strategy and pull-through plans we put forward to our clients. SCHEMA supports all divisions under BGB Group, ensuring flawless integration of a brand's access strategies into all we do. Our unique vantage point helps leverage HCP and patient campaigns across print, digital, and NPP channels to maximize performance. Seamless integration yields timing efficiencies, cost savings, consistent procedures, and most notable, a unified brand message across audiences and media. SCIOD Our boutique life science strategy consulting firm is designed to support our clients' forward momentum in the face of ever increasing complexity and scientific advancement. The success for products, portfolios, and companies as a whole is largely driven by strategic decisions made in the early stages of the lifecycle. We have elite minds with scientific backgrounds and diverse business experience on-staff, ready to bolster efforts including research development, pipeline analysis and prioritization, endpoint analysis, customer insight mining, franchise or corporate strategy, and lifecycle optimization planning.
New Roles
Roles Added
6
Roles
Jim Spencer - Chief Financial Officer
Growth
2022 Growth from Existing Clients
70%
2022 Growth from New Clients
30%
Trends and Challenges
Payer-related challenges
Pricing-related issues
Getting an audience, virtually or otherwise, with HCPs
Keeping up with pace of innovation
Replenishing new-business pipeline
Procurement-related issues
Network relationships/agency consolidation
Shrinking pharma budgets
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Ongoing fallout from societal unrest
Creative Samples
